Literature DB >> 8631546

Growth suppression of a cervical cancer cell line (TMCC-1) by the human wild-type p53 gene.

P S Zheng1, T Iwasaka, M Ouchida, K Fukuda, M Yokoyama, H Sugimori.   

Abstract

To investigate the effects of human wild-type p53 expression on the proliferation of cervical carcinoma cells, a plasmid, pMO7-hp53, which contains a full-length cDNA of the human wild-type p53 (wt-p53) gene, was transfected into a cell line (TMCC-1) derived from an endocervical type, human papilloma virus-positive adenocarcinoma of the uterine cervix. The exogenous wt-p53 expression induced growth suppression, morphological changes, and loss of anchorage-independent growth of the tumor cells. As the wt-p53 gene apparently plays a negative role in growth regulation of cervical carcinoma cells, this gene may possibly be of some use for treating subjects with a cervical carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631546     DOI: 10.1006/gyno.1996.0033

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  2 in total

1.  Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression.

Authors:  Taishi Akimoto; Akira Takasawa; Kumi Takasawa; Tomoyuki Aoyama; Masaki Murata; Makoto Osanai; Tsuyoshi Saito; Norimasa Sawada
Journal:  Neoplasia       Date:  2018-09-15       Impact factor: 5.715

2.  Aberrant expression of claudin-6 contributes to malignant potentials and drug resistance of cervical adenocarcinoma.

Authors:  Yui Ito; Akira Takasawa; Kumi Takasawa; Taro Murakami; Taishi Akimoto; Daisuke Kyuno; Yuka Kawata; Kodai Shano; Kurara Kirisawa; Misaki Ota; Tomoyuki Aoyama; Masaki Murata; Kotaro Sugimoto; Hideki Chiba; Tsuyoshi Saito; Makoto Osanai
Journal:  Cancer Sci       Date:  2022-02-13       Impact factor: 6.716

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.